Inicio › Carcinoma de células escamosas de cabeza y cuello › Oregón › Portland
Ensayos clínicos de Carcinoma de células escamosas de cabeza y cuello en Portland, OR
19 estudios para Carcinoma de células escamosas de cabeza y cuello buscan participantes en centros de Portland y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
ReclutandoFase 2/3
- Site #0113, Portland
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
ReclutandoFase 1
- Exelixis Clinical Site #51, Portland
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
ReclutandoFase 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
ReclutandoFase 1
- Site 02, Portland
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
ReclutandoFase 1
- ALX Center 6, Portland
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
ReclutandoFase 1
- Research Site, Portland
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
ReclutandoFase 3
- Oregon Health And Science University, Portland
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
ReclutandoFase 2
- Oregon Health and Science University, Portland
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
ReclutandoFase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
ReclutandoFase 3
- Oregon Health And Science University, Portland
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
ReclutandoFase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
ReclutandoFase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · A 12 mi de distancia
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
ReclutandoFase 2/3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- Providence Cancer Center Oncology and Hematology Care- Eastside, Portland
A Study of MGC026 in Participants With Advanced Solid Tumors
ReclutandoFase 1
- Providence Cancer Institute, Portland
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- Providence Cancer Institute Franz Clinic, Portland
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
ReclutandoFase 1
- Providence Cancer Institute Franz Clinic, Portland
- Providence Oncology and Hematology Care Clinic - Westside, Portland
- Providence St. Vincent Medical Center- Investigational Drug Services, Portland
- y 1 más
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
ReclutandoFase 4
- OHSU Knight Cancer Institute, Portland
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
ReclutandoFase 2
- USA15-0, Portland
Ensayos de Carcinoma de células escamosas de cabeza y cuello en otras ciudades
- Houston, TX47 estudios
- Los Angeles, CA42 estudios
- Boston, MA40 estudios
- Nashville, TN39 estudios
- New York City, NY39 estudios
- St. Louis, MO28 estudios
- Arlington, VA26 estudios
- Chicago, IL26 estudios
- Philadelphia, PA26 estudios
- Atlanta, GA24 estudios
- San Antonio, TX22 estudios
- Pittsburgh, PA22 estudios
Otros estudios en Portland
- Cáncer de pulmón de células no pequeñas46 estudios
- Cáncer (todos los tipos)34 estudios
- Cáncer de seno33 estudios
- Cáncer de próstata33 estudios
- Cáncer metastásico29 estudios
- Cáncer del colon y del recto28 estudios
- Cáncer de ovario27 estudios
- Cáncer de pulmón26 estudios
- Leucemia mielógena aguda25 estudios
- Cáncer de endometrio24 estudios
- Cáncer de páncreas19 estudios
- Fallo cardíaco17 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.